EMD Chemicals said that the StemSelect Library I is an expert selection of 303 pharmacologically active, cell-permeable (or cell receptor binding) InSolution modulators, many of which act in a reversible manner.
The library consists primarily of inducers, activators, agonists, antagonists and other related compounds that are shown to modulate cell fate; making it suitable for a variety of studies, including examination of cellular survival, migration, proliferation, invasion, differentiation, signaling pathway analysis and fate determination.
EMD Chemicals claimed that each library is supported with expert technical support and comprehensive documentation, including an SDF file that is provided in a CD with each package. Importantly, stringent stability and HPLC-purity testing on every batch of plates is conducted to ensure reliable results — the first time and every time.
Christina Shasserre, general manager of EMD Global Biosciences, said: “This library was developed to provide researchers with access to tools for discovery. It is a continuation of our expansion of stem-cell-research-related product offerings and a commitment to innovate the Calbiochem brand product portfolio.”
EMD Chemicals represents the North American chemical sector of Germany-based Merck KGaA.